ArticleInternational journal of hematology2024
Trametinib for a child with refractory Rosai-Dorfman-Destombes disease harboring a novel somatic mutation in MAP2K1.
Yuichi Taneyama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it